Seroatlas · Human Serome Atlas

OR6T1

Olfactory receptor 6T1

Also known as: OR6T1_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession: Q8NGN1
Gene: OR6T1
Ensembl: ENSG00000181499
Chromosome: 11
Canonical length: 323 aa
Protein class: G-protein coupled receptors, Predicted membrane proteins

OverviewNCBI Gene

Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

323 residues, UniProt reviewed canonical sequence.

>Q8NGN1|OR6T1
     1  MNPENWTQVT SFVLLGFPSS HLIQFLVFLG LMVTYIVTAT GKLLIIVLSW IDQRLHIQMY
    61  FFLRNFSFLE LLLVTVVVPK MLVVILTGDH TISFVSCIIQ SYLYFFLGTT DFFLLAVMSL
   121  DRYLAICRPL RYETLMNGHV CSQLVLASWL AGFLWVLCPT VLMASLPFCG PNGIDHFFRD
   181  SWPLLRLSCG DTHLLKLVAF MLSTLVLLGS LALTSVSYAC ILATVLRAPT AAERRKAFST
   241  CASHLTVVVI IYGSSIFLYI RMSEAQSKLL NKGASVLSCI ITPLLNPFIF TLRNDKVQQA
   301  LREALGWPRL TAVMKLRVTS QRK

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against OR6T1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability: Cell surface
Secreted: No
Transmembrane segments: 7
Mean surface accessibility (rSASA): 0.3
Highest tissue expression: 0.9 nTPM

Expression across tissuesHPA

Tissue

pancreas: 0.9 nTPM
testis: 0.3 nTPM
adipose tissue: 0 nTPM
adrenal gland: 0 nTPM
amygdala: 0 nTPM
appendix: 0 nTPM

Single-cell type

late primary spermatocytes: 0.5 nCPM
early spermatids: 0.1 nCPM
leydig cells: 0.1 nCPM
adipocytes: 0 nCPM
adrenal cortex cells: 0 nCPM
adrenal medulla cells: 0 nCPM

Immune cell

basophil: 0 nTPM
classical monocyte: 0 nTPM
eosinophil: 0 nTPM
gdT-cell: 0 nTPM
intermediate monocyte: 0 nTPM
MAIT T-cell: 0 nTPM

Brain region

cerebral cortex: 0.3 nTPM
hypothalamus: 0.3 nTPM
basal ganglia: 0.2 nTPM
hippocampal formation: 0.2 nTPM
amygdala: 0.1 nTPM
medulla oblongata: 0.1 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance): 1.44
gnomAD pLI: 0
gnomAD missense Z: -0.47
DepMap mean gene effect: 0.02
DepMap dependency class: none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Molecular functions

Cellular components

plasma membrane

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads OR6T1 as an antibody target. Whether an autoantibody or antibody against OR6T1 could matter depends on whether native OR6T1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

OR6T1 is annotated at the cell surface, where native OR6T1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label OR6T1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Loading the interactive Seroatlas protein explorer...